Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

North Shore Uranium Ltd NSU


Primary Symbol: V.NSU

North Shore Uranium Ltd., formerly Clover Leaf Capital Corp. is a Canada-based company, which is engaged in the exploration for uranium deposits at the eastern margin of Saskatchewan’s Athabasca Basin. The Company conducts its exploration programs on its two properties, the Falcon Property and the West Bear Property, and is evaluating opportunities to increase its portfolio of properties in the region. The Company has the option to acquire a 100% undivided interest in 11 claims that form approximately 77% of the Falcon Property.


TSXV:NSU - Post by User

Post by thorgb1on Apr 26, 2016 1:15pm
251 Views
Post# 24811115

Dundee research note.....

Dundee research note.....

For his part, Joseph Gallucci of Dundee Securities views the move as a positive for Nevsun, stating in a note to clients stating that the company has “put [its] cash balance to work (finally) to acquire a world class development project.”

More specifically, Dundee believes that the Timok project is a good fit for Nevsun. “Although it’s not in production, it’s only 5 years away from cash flow and is arguably similar to Bisha in terms of grade profile,” Gallucci added. Overall, Dundee reiterated its “buy, top pick” rating and $6.25 price target for Nevsun.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse